Dolutegravir (DTG) Use During Pregnancy and Birth Outcomes: Data from the Antiretroviral Pregnancy Registry (APR)

Press/Media

Period	13 Nov 2019

Media coverage

Title	Dolutegravir (DTG) Use During Pregnancy and Birth Outcomes: Data from the Antiretroviral Pregnancy Registry (APR)
Media name/outlet	National AIDS Treatment Advocacy Project
Country/Territory	United States
Date	13/11/19
URL	www.natap.org/2019/EACS/EACS_53.htm
Persons	Karen Beckerman